Cisatracurium Besylate Injection
Last Updated: September 9, 2016
Status: Current
Products Affected - Description
All presentations are currently available
Reason for the Shortage
Fresenius Kabi had cisatracurium besylate injection on shortage due to increased demand.
Available Products
Nimbex injection, AbbVie
2 mg/mL, 5 mL vial, 10 count (NDC 00074-4378-05)
2 mg/mL, 10 mL vial, 10 count (NDC 00074-4380-10)
10 mg/mL, 20 mL vial, 10 count (NDC 00074-4382-20)
Cisatracurium besylate injection, Fresenius Kabi
2 mg/mL, 5 mL vial, 10 count (NDC 63323-0416-05)
2 mg/mL, 5 mL vial, 10 count (NDC 63323-0416-05)
2 mg/mL, 10 mL vial, 10 count (NDC 63323-0417-10)
10 mg/mL, 20 mL vial, 10 count (NDC 63323-0418-20)
Cisatracurium besylate injection, Sandoz
2 mg/mL, 5 mL vial, 10 count (NDC 00781-3150-95)
2 mg/mL, 5 mL vial, 10 count (NDC 00781-3150-95)
2 mg/mL, 10 mL vial, 10 count (NDC 00781-3152-95)
10 mg/mL, 20 mL vial, 10 count (NDC 00781-3153-95)
Estimated Resupply Dates
All marketed presentations are available.
Related Shortages
- Pancuronium Injection — Resolved — No Commercially Available Preparations
Updated
September 9, August 25, July 28 and 7, June 9, May 24, April 14, 2016, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
